MedTrace Logo

Ibuprofen Versus Placebo For Muscle Soreness

NCT03228992 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2017-08-04

No results posted yet for this study

Summary

The study will assess the sensitivity of the Delayed Onset Muscle Soreness Model by comparing the safety and efficacy of oral ibuprofen to placebo over 24 hours.

Conditions

  • Muscle Soreness

Interventions

DRUG

Ibuprofen 400 mg

Subjects will receive 4 doses of oral ibuprofen over a 24 hour period.

OTHER

Placebo

Subjects will receive 4 doses of placebo over a 24 hour period.

Sponsors & Collaborators

  • Jean Brown Research

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2017-07-31
Completion
2017-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03228992 on ClinicalTrials.gov